EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Use of medication in pregnancy on the rise: Study on 1.4 million Danish pregnancies from 1998 to 2018

Mette Østergaard Thunbo iD, Julie Hauer Vendelbo iD, Daniel R Witte iD, Agnete Larsen iD, Lars Henning Pedersen iD

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14805 ↗

At a glance

Journal article in Acta Obstetricia et Gynecologica Scandinavica, 2024. Written by Mette Østergaard Thunbo and 4 co-authors. Institution: Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Major MEDLINE topics: Polypharmacy, Registries. Cited 32 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Novo Nordisk Fonden.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Maternal demographics have evolved, and more women than ever enter pregnancy with preexisting comorbidity and with potentially complex medication exposure, including polypharmacy (concomitant intake of multiple medications). This study aims to describe the evolution of medication use in pregnancy in Denmark from 1998 to 2018 with special focus on polypharmacy, patterns of use, and underlying demographics. Material and methods A Danish nationwide historical registry study based on all clinically recognized pregnancies with a gestation ≥10 weeks between 1998 and 2018. Medication use was estimated by redemption of prescriptions during pregnancy.

Results

Among a total of 1 402 327 clinically recognized pregnancies, redemption of at least one prescription medication during pregnancy increased from 56.9% in 1998 to 63.3% in 2018, coinciding with an increased use of polypharmacy (from 24.8% in 1998 to 35.2% in 2018). The prevalence of pregnant women who used medications for chronic conditions increased more than the prevalence of women treated for occasional or short‐time conditions. Redemption of one or multiple prescription medications during pregnancy was mostly seen among pregnant women ≥35 years of age. However, pregnant women

Subjects

MeSH terms (MEDLINE)

PolypharmacyRegistriesHumansFemalePregnancyDenmarkAdultPregnancy ComplicationsPrescription DrugsYoung Adult

Author keywords

drug utilizationmaternal agepolypharmacypregnancypregnancy trimestersprescription drugs

Substances

Prescription Drugs

Authors and institutions

  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.

ORCID profiles: Mette Østergaard Thunbo, Julie Hauer Vendelbo, Daniel R Witte, Agnete Larsen, Lars Henning Pedersen

Funding

  • Novo Nordisk Fonden

Cite

APA

Thunbo, M. Ø., Vendelbo, J. H., Witte, D. R., Larsen, A., & Pedersen, L. H. (2024). Use of medication in pregnancy on the rise: Study on 1.4 million Danish pregnancies from 1998 to 2018. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14805

Vancouver

Thunbo MØ, Vendelbo JH, Witte DR, Larsen A, Pedersen LH. Use of medication in pregnancy on the rise: Study on 1.4 million Danish pregnancies from 1998 to 2018. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14805

BibTeX
@article{Thunbo2024,
  author = {Thunbo, Mette Østergaard and Vendelbo, Julie Hauer and Witte, Daniel R and Larsen, Agnete and Pedersen, Lars Henning},
  title = {Use of medication in pregnancy on the rise: Study on 1.4 million Danish pregnancies from 1998 to 2018},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14805}
}
Start for free →